However, moderation is advisable and you should pay attention to how it affects your appetite, digestion, and overall diet
Another population-based cohort study of patients with T2DM with a concomitant cancer showed that no increased risk of metastasis was associated with DPP-4 inhibitor therapy (Noh et al., 2019)
Related Reading A Knoxville GLP-1 Notebook another perspective on this Knoxville Metabolic Health Notes related background reading NIDDK's overview of prescription weight-management medications background from a third-party source This site provides general educational information about GLP-1 weight loss (semaglutide and tirzepatide) and related care in Knoxville, Tennessee, and is independently maintained
Additionally, while the net effect on the heart is positive, the medication can cause a slight increase in resting heart rate
Food and Drug Administration for any medical, psychiatric, or cognitive indication
Most patients don't see significant weight loss in the first 46 weeks as the medication builds up